Hannah Brendan bought QNCX
December 5, 2025 · Form 4 insider transaction
Hannah Brendan bought 2,271 shares of Quince Therapeutics, Inc. at $0.55 per share, a transaction worth $1.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,271
Price
$0.55
Total value
$1.2K
InsiderHannah Brendan
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 5, 2025
Filing dateDecember 8, 2025
Shares owned after336,547
OwnershipDirect
10b5-1 planNo
AmendedNo